Keyphrases
Type 2 Diabetes Mellitus (T2DM)
95%
Type 2 Diabetic Patients
90%
Copenhagen
88%
Insulin Therapy
88%
Metformin
84%
Insulin Analogues
84%
Placebo
75%
Carotid Intima-media Thickness (cIMT)
71%
Metformin Therapy
59%
Weight Loss
57%
Obese Patients
51%
Hemoglobin A1c (HbA1c)
49%
Randomized Placebo-controlled Trial
41%
Insulin Dose
30%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
28%
Obesity
28%
Cardiac Contractility
28%
Muscle Glycogen
28%
Leptons
28%
Central Hemodynamics
28%
Glycemic Control
28%
Basal Insulin
28%
Bone Mineral Density
28%
PIIINP
28%
Cardiac Output
28%
Glycogen Synthase
28%
ATLAS Detector
28%
Blood Pressure Regulation
28%
Supersymmetry
28%
Kinase Activity
28%
Glucose Intolerance
28%
Primary Adrenal Lymphoma
28%
Insulin Receptor Kinase
28%
Fluoxetine
28%
Collagen Metabolism
28%
Oxygen Uptake
19%
Sympathetic Tone
19%
Central Blood Volume
19%
Body Mass Index
15%
Medicine and Dentistry
Placebo
100%
Glycon
85%
Patient with Type 2 Diabetes
61%
Maturity Onset Diabetes of the Young
57%
Intima-Media Thickness
41%
Hemoglobin A1c
40%
Cancellous Bone
28%
Collagen Metabolism
28%
Adrenal Insufficiency
28%
Procollagen
28%
Heart Output
28%
Heart Muscle Contractility
28%
Bone Density
28%
Clinical Study
28%
Ephedrine
28%
Diet Therapy
28%
Hemodynamic
28%
Insulin Treatment
26%
Blood Pressure
23%
Adverse Event
20%
Type 2 Diabetes
19%
Oxygen Consumption
19%
Central Blood Volume
19%
Sympathetic Tone
19%
Adrenal Gland
19%
Computer Assisted Tomography
19%
Diseases
19%
Nursing and Health Professions
Metformin
85%
Non Insulin Dependent Diabetes Mellitus
85%
Arterial Wall Thickness
69%
Patient with Type 2 Diabetes
61%
Placebo
61%
Hemoglobin A1c
57%
Glycogen Muscle Level
28%
Glucose Intolerance
28%
Glycogen Synthase
28%
Insulin Treatment
26%
Insulin Detemir
20%
Insulin Aspart
20%
Antidiabetic Agent
20%
Adverse Event
17%
Body Mass
16%
